According to AN2 Therapeutics's latest financial reports the company's current EPS (TTM) is -$5.04. In 2022 the company made an earnings per share (EPS) of -$8.47 a decrease over its 2021 EPS that were of -$3.32.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$4.58 | -45.87% |
2022 | -$8.47 | 154.79% |
2021 | -$3.32 |